Jim Kelly | Executive Vice President and Chief Financial Officer |
Mihael Polymeropoulos | President and Chief Executive Officer |
Jason Butler | JMP Securities |
Sarah James | Piper Jaffray |
Matthew Andrews | Jefferies |
Chris Liu | Oppenheimer |
Welcome to the Fourth Quarter 2017 Vanda Pharmaceuticals Incorporated Earnings Conference Call. My name is Hilda and I will be your operator for today. At this time all participants are in a listen-only mode. Later we will conduct a question-and-answer session. [Operator Instructions] Please note that this conference is being recorded.